This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $829,211 to New York University School of Medicine to conduct the VIS-HD Cohort Study. The study aims to:
- Characterize the prevalence, risk factors, and causes of vision impairment among the approximately 802,000 adults with end-stage kidney disease (ESKD) in the U.S.
- Identify the cognitive and vision-related outcomes associated with vision impairment in this patient population.
- Pinpoint barriers to correcting vision impairment and develop a multi-modal intervention to mitigate it.
The 5-year project will leverage NYU's existing infrastructure to enroll and assess a cohort of 300 ESKD patients across 16 dialysis centers. The findings will inform future interventions to address vision impairment and its impact on cognitive decline and dementia risk in this high-risk patient group.
Generated 1/28/25, 10:55 AM